Hepatic metabolism of the new antipsychotic agent, mazapertine, in rat - API-MS/MS identification of metabolites

被引：5

作者：

Wu, WN ^{[1
]}

McKown, LA ^{[1
]}

Reitz, AB ^{[1
]}

机构：

[1] Johnson & Johnson Pharmaceut Res & Dev, LLC, Spring House, PA 19477 USA

来源：

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 2003年 / 28卷 / 04期

关键词：

mazapertine; antipsychotic agent; rat hepatic S9; in vitro metabolism; ms/ms;

D O I：

10.1007/BF03220180

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The In vitro biotransformation of the antipsychotic agent, mazapertine was studied after incubation with rat hepatic S9 fraction in the presence of an NADPH-generating system. Unchanged mazapertine (42% of the sample) plus 12 metabolites were profiled, quantified, and tentatively identified on the basis of API (ionspray)-MS/MS data. The proposed metabolic pathways for mazapertine are proposed, and the 6 metabolic pathways are: (1) phenylhydroxylation, (2) piperidyl oxidation, (3) O-dealkylation, (4) N-dephenylation, (5) oxidative N-debenzylation, and (6) dehydration. Pathways 1 to 3 formed 4-OH-phenyl (M1, 10%) and 4-OH-piperidyl (M2, 9%)-mazapertine, O-desisopropyl mazapertine (M3, 17%), and N-desbenzoylpiperidine-mazapertine (M8, 14%) as 4 major metabolites. Mazapertine is extensively metabolized in rat hepatic S9 fraction.

引用

页码：279 / 286

页数：8

共 12 条

[1]

BUCLIN T, 1993, 94 ANN M AM SOC CLIN

[2]

BUCLIN T, 1993, SCHWEIZERISCHE MED W, V123, P39

[3]

Gisclon L. G., 1993, Pharmaceutical Research (New York), V10, pS398

[4] The synthesis and evaluation of the major metabolites of mazapertine [J].

Reitz, AB ;

McDonnell, ME ;

Baxter, EW ;

Codd, EE ;

Wu, WN .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (14) :1927-1930

[5] A NEW ARYLPIPERAZINE ANTIPSYCHOTIC WITH HIGH D-2/D-3/5-HT1A/(ALPHA(1A))-ADRENERGIC AFFINITY AND A LOW POTENTIAL FOR EXTRAPYRAMIDAL EFFECTS [J].

REITZ, AB ;

BENNETT, DJ ;

BLUM, PS ;

CODD, EE ;

MARYANOFF, CA ;

ORTEGON, ME ;

RENZI, MJ ;

SCOTT, MK ;

SHANK, RP ;

VAUGHT, JL .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (08) :1060-1062

[6]

Wu W. N., 1994, Pharmaceutical Research (New York), V11, pS336

[7] Biotransformation of the antipsychotic agent, mazapertine, in dog - mass spectral characterization and identification of metabolites [J].

Wu, WN ;

McKown, LA ;

Takacs, AR ;

Jones, WJ ;

Reitz, AB .

XENOBIOTICA, 1999, 29 (05) :453-466

[8] In vitro biotransformation of the new antipsychotic agent, RWJ-46344 in rat hepatic S9 fraction: API-MS/MS/MS identification of metabolites [J].

Wu, WN ;

McKown, LA ;

Moyer, MD ;

Reitz, AB .

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 24 (02) :307-316

[9]

WU WN, 1995, P 43 ASMS C MASS SPE, P56

[10]

WU WN, 1997, ISSX P, P161

← 1 2 →